Methotrexate for psoriatic arthritis-Reference-Cited by-同舟云学术

Methotrexate for psoriatic arthritis

Published:2019-01-18 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Wilsdon Tom D¹,Whittle Samuel L²,Thynne Tilenka RJ³,Mangoni Arduino A³

Affiliation:

1. Royal Adelaide Hospital and University of Adelaide; Department of Rheumatology; Port Rd Adelaide South Australia Australia 5000

2. The Queen Elizabeth Hospital and University of Adelaide; Department of Rheumatology; 28 Woodville Road Woodville South Australia Australia 5011

3. Flinders Medical Centre and Flinders University; Department of Clinical Pharmacology; Flinders Drive Bedford Park South Australia Australia 5042

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012722.pub2/epdf/full

Reference135 articles.

1. Efficacy and safety of leflunomide in psoriatic arthritis;Asaduzzaman;Journal of the Pakistan Association of Dermatology,2014

2. Methotrexate therapy in psoriatic arthritis: double-blind study on 21 patients;Black;Journal of the American Medical Association,1964

3. The comparative efficacy of slow-acting (basic) preparations in psoriatic arthritis;Burdeinyi;Terapevticheskii Arkhiv,1992

4. Quality of life in psoriatic arthritis: comparative results with rheumatoid arthritis using SF36 in trials using methotrexate;Kingsley;Rheumatology (Oxford),2012

5. Methotrexate is not disease modifying in psoriatic arthritis: the MIPA trial;Kingsley;Arthritis and Rheumatism,2010

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of spondyloarthritis with disease-modifying anti-rheumatic drugs during pregnancy and breastfeeding: comparing the recommendations and guidelines of the principal societies of rheumatology;Reumatismo;2024-09-11

2. Early psoriatic arthritis: clinical and therapeutic challenges;Expert Opinion on Investigational Drugs;2024-08-07

3. Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52‐Week Results From Two Phase 3 Studies;ACR Open Rheumatology;2024-07-30

4. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update;Annals of the Rheumatic Diseases;2024-03-18

5. Methotrexate for juvenile idiopathic arthritis;Cochrane Database of Systematic Reviews;2024-02-09